Lannett (LCI) Tops Q2 EPS by 1c, Reaffirms FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Lannett Reports Fiscal 2016 Second Quarter Results
February 3, 2016 4:16 PM ESTPHILADELPHIA, Feb. 3, 2016 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2016 second quarter and first six months ended December 31, 2015. As previously announced, the company completed the acquisition of Kremers Urban Pharmaceuticals Inc. (KU) on November 25, 2015. Accordingly, fiscal 2016 second quarter and year-to-date financial results include the operations of KU since the acquisition date.Â
For the fiscal 2016 second quarter, net sales increased to $127.1 million from $114.8 million in last year's second quarter. Gross profit was $71.6 million, or 56% of net... More



